Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infection

Nature

Volumn 481, Issue 7381, 2012, Pages 371-375

  Jäger, Stefanie ^a,b   Kim, Dong Young ^c   Hultquist, Judd F ^d   Shindo, Keisuke ^d   Larue, Rebecca S ^d   Kwon, Eunju ^c   Li, Ming ^d   Anderson, Brett D ^d   Yen, Linda ^c   Stanley, David ^c   Mahon, Cathal ^a,b,c   Kane, Joshua ^a,b   Franks Skiba, Kathy ^a,b   Cimermancic, Peter ^b,e   Burlingame, Alma ^b,c   Sali, Andrej ^b,c,e   Craik, Charles S ^b,c   Harris, Reuben S ^d   Gross, John D ^b,c   Krogan, Nevan J ^a,b,c,f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e San Francisco   (United States)

^f GLADSTONE INSTITUTES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; CORE BINDING FACTOR BETA; DNA BINDING PROTEIN; RNA; VIF PROTEIN;

BIODEGRADATION; ENZYME ACTIVITY; GENETIC ANALYSIS; HUMAN IMMUNODEFICIENCY VIRUS; MASS SPECTROMETRY; PROTEIN; RECOMBINATION;

ARTICLE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; SIMIAN IMMUNODEFICIENCY VIRUS;

AFFINITY LABELS; ANIMALS; CORE BINDING FACTOR BETA SUBUNIT; CULLIN PROTEINS; CYTIDINE DEAMINASE; GENE KNOCKDOWN TECHNIQUES; GENE PRODUCTS, VIF; GENETIC COMPLEMENTATION TEST; HEK293 CELLS; HIV INFECTIONS; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; JURKAT CELLS; MACACA MULATTA; MASS SPECTROMETRY; MODELS, BIOLOGICAL; PROTEIN BINDING; PROTEOLYSIS; SIMIAN IMMUNODEFICIENCY VIRUS; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION; VIF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; VIRUS REPLICATION;

AIDS VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA MULATTA; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 84856009926     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature10693     Document Type: Article

References (28)

1. Goff, S. P. Retrovirus restriction factors. Mol. Cell 16, 849-859 (2004). (Pubitemid 40018396)
2. Malim, M. H.& Emerman, M. HIV-1 accessory proteins-ensuring viral survival in a hostile environment. Cell Host Microbe 3, 388-398 (2008). (Pubitemid 351784365)
3. Albin, J. S.& Harris, R. S. Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics. Expert Rev. Mol. Med. 12, e4 (2010).
4. Yu, X. et al. Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 302, 1056-1060 (2003). (Pubitemid 37386201)
5. Mehle, A.,Goncalves, J.,Santa-Marta,M.,McPike, M.&Gabuzda, D.Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APOBEC3G degradation. Genes Dev. 18, 2861-2866 (2004). (Pubitemid 39602304)
6. Mehle, A. et al. Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway. J. Biol. Chem. 279, 7792-7798 (2004). (Pubitemid 38294663)
7. Sheehy, A. M.,Gaddis, N. C., Choi, J. D.&Malim, M. H. Isolation of a humangene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418, 646-650 (2002).
8. Sheehy, A. M., Gaddis, N. C.&Malim, M. H. The antiretroviral enzymeAPOBEC3Gis degraded by the proteasome in response to HIV-1 Vif. Nature Med. 9, 1404-1407 (2003). (Pubitemid 37466190)
9. Conticello, S. G., Harris, R. S. & Neuberger, M. S. The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G. Curr. Biol. 13, 2009-2013 (2003). (Pubitemid 37425213)
10. Stopak, K., de Noronha, C., Yonemoto, W. & Greene, W. C. HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability. Mol. Cell 12, 591-601 (2003). (Pubitemid 37222482)
11. Passmore, L. A. & Barford, D. Getting into position: the catalytic mechanisms of protein ubiquitylation. Biochem. J. 379, 513-525 (2004). (Pubitemid 38703635)
12. Thrower, J. S., Hoffman, L., Rechsteiner, M. & Pickart, C. M. Recognition of the polyubiquitin proteolytic signal. EMBO J. 19, 94-102 (2000). (Pubitemid 30009229)
13. Stanley, B. J. et al. Structural insight into the human immunodeficiency virus Vif SOCS box and its role in human E3 ubiquitin ligase assembly. J. Virol. 82, 8656-8663 (2008).
14. Jäger, S. et al. Purification and characterization of HIV-human protein complexes. Methods 53, 13-19 (2011).
15. Jäger, S. et al. Global landscape of HIV-human protein complexes. Nature doi:10.1038/nature10719 (this issue).
16. Kamura, T. et al.VHL-box andSOCS-boxdomains determinebinding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases. Genes Dev. 18, 3055-3065 (2004). (Pubitemid 39658174)
17. Huang, D. T. et al. E2-RING expansion of the NEDD8 cascade confers specificity to cullin modification. Mol. Cell 33, 483-495 (2009).
18. Wong, W. F., Kohu, K., Chiba, T., Sato, T. & Satake, M. Interplay of transcription factors in T-cell differentiation and function: the role of Runx. Immunology 132, 157-164 (2011).
19. Petroski, M. D. & Deshaies, R. J. Mechanism of lysine 48-linked ubiquitin-chain synthesis by the cullin-RING ubiquitin-ligase complex SCF-Cdc34. Cell 123, 1107-1120 (2005). (Pubitemid 41785424)
20. Kim,H. T. et al. Certainpairs ofubiquitin-conjugatingenzymes (E2s) and ubiquitinprotein ligases (E3s) synthesize nondegradable forked ubiquitin chains containing all possible isopeptide linkages. J. Biol. Chem. 282, 17375-17386 (2007).
21. DeHart, J. L.,Bosque, A.,Harris, R. S.&Planelles, V.Humanimmunodeficiency virus type 1 Vif induces cell cycle delay via recruitment of the same E3 ubiquitin ligase complex that targets APOBEC3 proteins for degradation. J. Virol. 82, 9265-9272 (2008).
22. Stenglein, M. D., Burns, M. B., Li, M., Lengyel, J. & Harris, R. S. APOBEC3 proteins mediate the clearance of foreign DNA from human cells. Nature Struct. Mol. Biol. 17, 222-229 (2010).
23. Hultquist, J. F. et al. Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1. J. Virol. 85, 11220-11234 (2011).
24. Rodrigo-Brenni, M. C. & Morgan, D. O. Sequential E2s drive polyubiquitin chain assembly on APC targets. Cell 130, 127-139 (2007). (Pubitemid 47031321)
25. Wu, K., Kovacev, J.&Pan, Z. Q. Priming and extending: a UbcH5/Cdc34 E2 handoff mechanism for polyubiquitination on a SCF substrate. Mol. Cell 37, 784-796 (2010).
26. Koning, F. A. et al. Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets. J. Virol. 83, 9474-9485 (2009).
27. Refsland, E. W. et al. Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction. Nucleic Acids Res. 38, 4274-4284 (2010).
28. Saha, A. & Deshaies, R. J. Multimodal activation of the ubiquitin ligase SCF by Nedd8 conjugation. Mol. Cell 32, 21-31 (2008).